Outlook Therapeutics, Inc. (OTLK) ownership: Top institutional holder: Schonfeld Strategic Advisors LLC ($3.86M). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 2441355.00 | $3.86M | 2025-12-31 |
| VANGUARD GROUP INC | 1465167.00 | $2.31M | 2025-12-31 |
| Sio Capital Management, LLC | 1125400.00 | $1.78M | 2025-12-31 |
| ARMISTICE CAPITAL, LLC | 4168000.00 | $857774.00 | 2026-03-31 |
| MARSHALL WACE, LLP | 298456.00 | $471560.00 | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1967160.00 | $405235.00 | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 164498.00 | $259907.00 | 2025-12-31 |
| ADAR1 Capital Management, LLC | 100000.00 | $158000.00 | 2025-12-31 |
Back to OTLK overview · OTLK earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.